Cancer-Research to Treatment: an Accelerating Journey
Fuad Ameen
Department of botany and microbiology, Faculty of Science, king Saud University, Riyadh11451, Saudi Arabia.
Corresponding Author E-mail: alfouad2004@hotmail.com
DOI : http://dx.doi.org/10.13005/bbra/2444
ABSTRACT:
The discovery a single gene had a revolutionary impact on healthcare on the basis of work done by Dr. Mary-Claire King at the University of California in Berkeley because he discovered that a single gene was responsible for certain breast cancers and it changed the diagnosis. In the latter half of 1990, genetics was considered to be a vital aspect and hence the Human Genome Project was launched. The rate of Breast cancer had dramatically increased over the last decade with respect to the improvements in screening by mammograms but still thousands of women do not have access to screening or diagnostics because of a lack in funding. Hence, we were in need of a new testing method to inspire the genetic discovery of Dr. King but a link was not established between genetic and clinical practice in oncology and there raised an urge to investigate the concept of “personalized medicine”. In this review, we investigate the concept of personalized medicine.
KEYWORDS:
Dramatically; Mammogram; Screening; Diagnostics
Download this article as:![icon_pdf](https://agriculturejournal.org/wp-content/uploads/2014/03/icon_pdf.png)
Copy the following to cite this article: Ameen F. Cancer-Research to Treatment: an Accelerating Journey. Biosci Biotech Res Asia 2017;14(1).1). |
Copy the following to cite this URL: Ameen F. Cancer-Research to Treatment: an Accelerating Journey. Biosci Biotech Res Asia 2017;14(1). Available from: https://www.biotech-asia.org/?p=22991 |